These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 407759)

  • 1. Effect of prolonged oral administration of TRH on plasma levels of thyrotrophin and prolactin in normal individuals and in patients with primary hypothyroidism.
    Frey HM; Haug E
    Acta Endocrinol (Copenh); 1977 Aug; 85(4):744-52. PubMed ID: 407759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum thyrotropin and prolactin in the syndrome of generalized resistance to thyroid hormone: responses to thyrotropin-releasing hormone stimulation and short term triiodothyronine suppression.
    Sarne DH; Sobieszczyk S; Ain KB; Refetoff S
    J Clin Endocrinol Metab; 1990 May; 70(5):1305-11. PubMed ID: 2110573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of dopaminergic inhibition on serum levels of thyrotrophin and prolactin in patients with hypothyroidism before and after prolonged oral administration of TRH.
    Frey HM; Haug E
    Acta Endocrinol (Copenh); 1983 Oct; 104(2):183-8. PubMed ID: 6415988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma thyrotropin-releasing hormone, prolactin, thyrotropin, and thyroxine concentrations following the intravenous or oral administration of thyrotropin-releasing hormone.
    Andreassen B; Huth J; Tyson JE
    Am J Obstet Gynecol; 1979 Nov; 135(6):737-42. PubMed ID: 115316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns off recovery of the hypothalamic-pituitary-thyroid axis in patients taken of chronic thyroid therapy.
    Krugman LG; Hershman JM; Chopra IJ; Levine GA; Pekary E; Geffner DL; Chua Teco GN
    J Clin Endocrinol Metab; 1975 Jul; 41(1):70-80. PubMed ID: 807596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The hypothalamic-Pituitary thyroid axis: studies on the regulatory role of thyrotropin releasing hormone (TRH) (author's transl)].
    Hirooka Y
    Nihon Naibunpi Gakkai Zasshi; 1976 Sep; 52(9):908-25. PubMed ID: 828584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repetitive administration of thyrotropin-releasing hormone results in small elevations of serum thyroid hormones and in marked inhibition of thyrotropin response.
    Snyder PJ; Utiger RD
    J Clin Invest; 1973 Sep; 52(9):2305-12. PubMed ID: 4199417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmentation of pituitary thyrotrophin response to thyrotrophin releasing hormone during subphysiological tri-iodothyroinine therapy in hypothyroidism.
    Ridgway EC; Kourides IA; Chin WW; Cooper DS; Maloof F
    Clin Endocrinol (Oxf); 1979 Apr; 10(4):343-53. PubMed ID: 113139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained rises in serum thyrotropin, thyroxine, and triiodothyronine during long term, continuous thyrotropin-releasing hormone treatment in patients with amyotrophic lateral sclerosis.
    Kaplan MM; Taft JA; Reichlin S; Munsat TL
    J Clin Endocrinol Metab; 1986 Oct; 63(4):808-14. PubMed ID: 3091628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid-stimulating hormone, prolactin, and growth hormone response to thyrotropin-releasing hormone in treated children with congenital hypothyroidism.
    Sack J; Shafrir Y; Urbach D; Amado O
    Pediatr Res; 1985 Oct; 19(10):1037-9. PubMed ID: 3932951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of oral and intravenous TRH and metoclopramide on PRL and TSH secretion in women.
    Kauppila A; Ylikorkala O
    Clin Endocrinol (Oxf); 1982 Dec; 17(6):617-23. PubMed ID: 6819904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of iodine upon the TRH induced release of TSH in euthyroid, hypothyroid and hyperthyroid individuals.
    Waldhäusl W; Haydl H
    Horm Metab Res; 1976 Jul; 8(4):286-91. PubMed ID: 821840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of long-term low dose thyrotropin-releasing hormone infusions on serum thyrotropin and prolactin concentrations in man.
    Spencer CA; Greenstadt MA; Wheeler WS; Kletzky OA; Nicoloff JT
    J Clin Endocrinol Metab; 1980 Oct; 51(4):771-5. PubMed ID: 6774994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seasonal variation of serum thyrotropin concentration and thyrotropin response to thyrotropin-releasing hormone in patients with primary hypothyroidism on constant replacement dosage of thyroxine.
    Konno N; Morikawa K
    J Clin Endocrinol Metab; 1982 Jun; 54(6):1118-24. PubMed ID: 6804476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of thyrotropin, prolactin, growth hormone, triiodothyronine and thyroxine after oral administration of thyrotropin releasing hormone in hypothyroid and hyperthyroid patients.
    Nedvídková J; Felt V
    Endokrinologie; 1976; 68(2):175-82. PubMed ID: 827434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship of serum thyrotropin (TSH) to the thyroid hormones after oral TSH-releasing hormone in patients with preclinical hypothyroidism.
    Staub JJ; Noelpp B; Gräni R; Gemsenjäger E; Hauenstein M; Girard J
    J Clin Endocrinol Metab; 1983 Mar; 56(3):449-53. PubMed ID: 6401757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of hypothyroidism and hypoprolactinemia by growth hormone producing rat pituitary tumors.
    Seo H; Refetoff S; Fang VS
    Endocrinology; 1977 Jan; 100(1):216-26. PubMed ID: 401484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of tartrate thyrotropin-releasing hormone treatment on serum thyrotropin, free triiodothyronine, free thyroxine and prolactin levels in patients with spinocerebellar degeneration.
    Merola B; Colao A; Di Renzo G; Filla A; Campanella G; Lombardi G
    Horm Res; 1992; 38(3-4):160-3. PubMed ID: 1306848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Iopanoic acid on the pituitary-thyroid axis: time sequence of changes in serum iodothyronines, thyrotropin, and prolactin concentrations and responses to thyroid hormones.
    Suzuki H; Noguchi K; Nakahata M; Nakagawa S; Kadena N
    J Clin Endocrinol Metab; 1981 Oct; 53(4):779-83. PubMed ID: 6793610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyrotropin-releasing hormone in critical illness: from a dopamine-dependent test to a strategy for increasing low serum triiodothyronine, prolactin, and growth hormone concentrations.
    Van den Berghe G; de Zegher F; Vlasselaers D; Schetz M; Verwaest C; Ferdinande P; Lauwers P
    Crit Care Med; 1996 Apr; 24(4):590-5. PubMed ID: 8612408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.